ADVANTICS™ LAAC Solution

Grow your LAAC programme

Designed to pro-actively flag potential Left Atrial Appendage Closure (LAAC) patients within your hospital
ADVANTICS™ LAAC Solution
Treat more LAAC patients within your hospital through a digital, multi-disciplinary approach helping to protect more patients from Atrial Fibrillation-related stroke.

Key Resources


 
Is your organisation ready?
ADVANTICS™ LAAC Solution

Designed to pro-actively flag potential LAAC patients in your hospital who are suitable for treatment.
Designed to...
1
...easly flag potential
LAAC patients

1
...activate and treat
more patients
1
...accelerate the
patient path

 
Jean Franke CEO, Sana Klinikum Lichtenberg, Berlin, Germany

Jean Franke
CEO, Sana Klinikum Lichtenberg, Berlin (Germany)

“Working with Boston Scientific has allowed us to expand and professionalize the LAAC program in the cardiology department. Through the collaboration of the clinical team, the IT department and the ADVANTICS team from Boston Scientific, we were able to develop innovative approaches that are now being implemented across the Sana group.”

 

Explore outcomes to grow your LAAC programme


Learn how Dr Olaf Göing from Sana Klinikum Lichtenberg (Berlin, Germany) could double the number of patients undergoing LAAC over 18 months with the ADVANTICS™ LAAC Solution1. Additional patients could benefit from this therapy, thanks to a live flagging of potential candidates within his own hospital and a stronger interdisciplinary collaboration. 
Jean Franke CEO, Sana Klinikum Lichtenberg, Berlin, Germany

Dr Olaf Göing's experience with
the ADVANTICS™ LAAC Solution

 

Strengthening the cardiovascular service to support LAAC therapy growth

Sana Klinikum Lichtenberg, Berlin
Case study


Sana Kliniken AG expressed an interest to enhance patient access to LAAC and its clinic service in the Berlin area. Find out how the partnership has driven sustainable results in 18 months
434 potential patients within 11 months of activity
74% eligible for further screening
Growth of the LAAC offering by 1,8x
Efficient screening and new resources brought together to support awareness activities for the therapeutic option
6 additional hospitals enrolled in the programme in 2020

Sana Klinikum Lichtenberg, Berlin, Germany. October 2018 to April 2020. Outcomes from a real ADVANTICS programme. Results from case studies are not predictive of results in other cases. Results in other cases may vary.

Read the case study

 
Jean Franke CEO, Sana Klinikum Lichtenberg, Berlin, Germany

Pr. Gilles Rioufol
Head of Interventional Cardiology and Hemodynamic
Hospices Civils de Lyon, HCL, (France)

“We found in Boston Scientific a real partner to develop our service, combining both deep commitments to work alongside us, and real knowledge about the therapy. Working together on our communication strategy, on patient and referrer activation, on patient flow constraints and on the overall LAAC programme organisation.”

 

Creating opportunities for growth and delivering complete healthcare pathway

Hospices Civils de Lyon, HCL, (France)
Case study


Hospices Civils de Lyon (HCL) has been delivering exemplary care for over 200 years. Discover how a collaboration with Boston Scientific helped HCL evolve their LAAC experience, identify potential opportunities, implement a strategy for growth, deliver a complete patient healthcare pathway and achieve their business objectives.
Increased LAAC volume more than 2x versus baseline
Flagged 223 potential patients in the 12 months history of the hospital prior to the programme
Delivered 20% reduction in procedure duration and length of stay
Increased patient activation rate by 35% by expending number of referrers by x4

Hospices Civils de Lyon, France. February 2018 to February 2020. Outcomes from a real ADVANTICS programme. Results from case studies are not predictive of results in other cases. Results in other cases may vary.

Read the case study

Top